N
PBYI icon

Natixis’s Puma Biotechnology PBYI Stock Holding History

Natixis’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-27,615
Closed -$351K – 896
2019
Q2 		$351K Buy
+27,615
New +$636K ﹤0.01% 644
2018
Q3 		– Sell
-9,532
Closed -$564K – 938
2018
Q2 		$564K Sell
9,532
-1,290
-12% -$74.8K ﹤0.01% 679
2018
Q1 		$736K Buy
10,822
+1,631
+18% +$122K ﹤0.01% 629
2017
Q4 		$909K Buy
9,191
+2,743
+43% +$307K 0.01% 515
2017
Q3 		$772K Buy
+6,448
New +$600K 0.01% 560

Other funds holding PBYI

PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return